Tag: drug trial development

Complete cancer remission in drug trial development

June 8, 2022

A small clinical trial of the drug dostarlimab in the US has virtually rid each of its 18 participants of colorectal cancer, one of the most dangerous common cancers known to man. Doctors, stunned with the effectiveness of the drug, are now expanding the trial to include gastric, prostate, and pancreatic cancer patients. Dostarlimab (TSR-042) […]

Continue Reading